Managing Market Access Launch Activities


Cutting Edge Information designed Managing Market Access Launch Activities to guide brand managers and market access teams through key market access launch activities during the 12 months leading up to – as well as the 12 months following -launch. This detailed benchmarking study explores timelines and coordination tactics for market access strategies, payer relationship management and global launch sequencing.

Download Now! speak-to-an-expert


This report is a comprehensive study on medical education.  Learn how to manage time, the scarcest resource: activities are compressed into tight 6- or 12-month planning windows.

Managing Market Access Launch Activities: Benchmarking Product Commercialization and Cross-Functional Coordination focuses on typical product launches, not the market access function as a whole. Overall findings will address things like:

  • Market access strategies
  • Timing
  • Payer relationships
  • Global coordination


  • 3 chapters + an Executive Summary
  • 300+ metrics
  • 53 graphics

Data have been split by team region:

  • Global
  • Country-Level

Data have also been split by company size:

  • Top 10
  • Top 50
  • Small
  • Device

Portfolio size:

  • Large
  • Medium
  • Small

Top Reasons to Buy Managing Market Access Launch Activities

Manage market access activity timelines: For many surveyed groups, the scarcest resource is time, as a slew of activities are compressed into tight 6- or 12-month planning windows. This study provides data and benchmarking metrics on market access strategy and timing. Data show companies’ functional involvement in specific market access launch activities. Internal functions examined include market access, managed markets and marketing groups. Further data also highlight both current and ideal activity timing across a range of market access responsibilities.

Master payer relationship management at launch: Market access considerations around launch primarily revolve around meeting payer needs and making sure that value dossiers respond to payer priorities. This study spotlights the need to initiate preparations for submitting health technology assessments (HTAs) to payers early in the product lifecycle — both in the US and Europe. This report also showcases data on payer relationship management. For instance, many surveyed teams begin talking with payers by the time their product enters Phase 3 — and some start even earlier — to ensure that payer priorities are addressed. Responding to payer priorities successfully is an essential part of paving the way for global launch success.

Coordinate global pharmaceutical launch activities: Resource allocation during product launch is particularly demanding for market access teams, regardless of company size or number of products. Planning and early involvement go a long way toward avoiding potential pitfalls during this period, but launch still represents a peak in terms of market access teams’ workload. Managing Market Access Launch Activities examines how to allocate pricing and health economics resources effectively during the launch window. It also explores how to develop and maintain a global launch sequence, a critical process that supports successful pharmaceutical launches.

You may also be interested in Cutting Edge Information’s Market Access library

be responsible for recruiting speakers.

Excerpt from Managing Market Access Launch Activities

Life science organizations must implement a number of market access activities —ranging from global launch sequencing to payer relationship management — leading up to brand commercialization. For successful product launches, firms should begin these activities well in advance to better meet fluctuating economic trends and evolving regulatory expectations. Market access teams must also have time to collect key supporting data — including health economics and outcomes research (HEOR), patient-reported outcomes (PROs) and comparative effectiveness research (CER). In today’s regulatory environment, these data play a critical role in payer relationship management and market access discussions.

Surveyed pharmaceutical and device firms recognize the importance of beginning market access activities early in the product lifecycle.  Across all activities, surveyed companies begin the task prior to product launch. Start times range from an average 3.3 months prior to launch for PROs to 15.1 months pre-launch for launch sequencing tasks.

Examples of companies that have participated in this study:

Managing Market Access Launch Activities Participation List